Hematology
News
Drugs
Xagena Medicine
Xagena.net
Chronic myeloid leukaemia: Glivec proves safe and effective over the long term
Hepatitis C: Pegasys reduces viral levels but does not slow or prevent the progression of serious liver disease
Pharmacogenetics of antileukemic drug toxicity
Low-dose Dexamethasone combined with Lenalidomide prolongs survival compared with high-dose Dexamethasone in patients with multiple myeloma
Five-year study shows Imatinib's excellent survival rate
Chronic myelogenous leukemia: high overall survival after five years on Gleevec
Multiple myeloma: Thalidomide and Dexamethasone more efficacious than Dexamethasone alone
A gene expression signature for Burkitt lymphoma identified
Chronic myeloid leukemia: Dasatinib circumvents Imatinib resistance
Chronic myelogenous leukaemia: Nilotinib when Imatinib fails
TNF level predicts who will develop deadly complication after bone marrow transplant
Oncaspar for newly-diagnosed acute lymphoblastic leukemia
CBFB-SMMHC, an oncoprotein, induces abnormal preleukemic blood cell progenitors
Infectious agents pose new risks for people with bleeding disorders
Vorinostat in patients with advanced, refractory cutaneous T-cell lymphoma
Pediatric acute myeloid leukaemia: accurate prediction of treatment response improves outcome
Chronic lymphocytic leukaemia: benefit of green tea
Advances in treatment of chronic myeloid leukaemia
Myelodysplastic syndrome: improvements in hemoglobin levels and fatigue after Aranesp
AMG 531 increases platelets in patients with immune thrombocytopenic purpura
AMN107 offers benefits in some forms of leukemia that are resistant to Gleevec
Biochemical connection between hepatitis C virus and liver cancer identified
B cell lymphomas and other EBV-associated illnesses: role of Epstein-Barr virus protein, EBNA3C
Inhaled nitric oxide may help sickle cell disease
Menin in the development of some forms of acute leukemia
Patients surviving childhood Hodgkin disease suffer strokes later in life
Acute myeloid leukemia, ERG may play a key role in leukemia development
Chronic myelogenous leukaemia, Forskolin may be effective in Imatinib-resistant patients
Hematopoietic-cell transplantation, protective conditioning protects against GVHD
Zevalin regimen associated with severe cutaneous or mucocutaneous reactions
Next Pages [
1
]
2
3
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions
